In addition to their role in reverse cholesterol transport, normal HDL particles can inhibit some of the atherogenic processes that occur in people with MetS and T2D, including increased oxidation [47-49], vascular inflammation [50,51], thrombosis [52], endothelial dysfunction [53], and reduced insulin sensitivity [54-56]. Here, INS is linked to metabolic syndrome.